WHO ICTRP trial
A trial to compare the effects of nebivolol versus atenolol on various…
EUCTR2005-001214-40-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-001214-40-GB |
|---|---|
| Public title | A trial to compare the effects of nebivolol versus atenolol on various cardiovascular measurements including insulin sensitivity - Nebivolol trial |
| Scientific title | A trial to compare the effects of nebivolol versus atenolol on various cardiovascular measurements including insulin sensitivity - Nebivolol trial |
| Primary sponsor | Imperial College London |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | United Kingdom |
| Conditions | Hypertension |
| Interventions | Trade Name: Atenolol Product Name: Atenolol Pharmaceutical Form: Tablet Trade Name: Nebliet Pharmaceutical Form: Tablet |
| Registration date | Jan 8, 2007 |
| Target size | 50 |
| Secondary IDs | cro085 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: